DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Namour F, Diderichsen PM, Cox E. et al.
Pharmacokinetics and pharmacokinetic/pharmacodynamic modeling of
filgotinib (GLPG0634), a selective JAK1 inhibitor, in support of Phase IIB dose
selection.
Clin Pharmacokinet 2015;
54: 859-874
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.